Injection site redness may appear and resolve within 24 to 48 hours
SCFAs promote metabolic pathways, including acetyl-coenzyme A biosynthesis, oxidative phosphorylation, glycolysis, and fatty acid biosynthesis ( Aicda and Prdm1 , thereby supporting B-cell differentiation and maturation ( 2.4 C
GLP-1 induced weight loss is an additive feature, which also independently helps reduce inflammation and improve healing
Following the March 20, 2026, patent expiry for Novo Nordisk's semaglutide, major Indian drugmakers including Sun Pharmaceuticals, Dr Reddy's Laboratories, Natco Pharma, Zydus Lifesciences, and Eris Lifesciences have rapidly launched their own generic GLP-1 treatments
The FDA-approved labeling for tirzepatide states that pancreatitis has been observed in clinical trials